Dr. Badar M. Mian, MD
Claim this profileAlbany Medical Center
Area of expertise
Prostate Cancer
Badar M. Mian, MD has run 3 trials for Prostate Cancer. Some of their research focus areas include:
Prostate-Specific Antigen
Badar M. Mian, MD has run 2 trials for Prostate-Specific Antigen.
Affiliated Hospitals
Albany Medical Center
Clinical Trials Badar M. Mian, MD is currently running
Anti-inflammatory Drugs
for Elevated Prostate-Specific Antigen Levels
Prostate cancer is the most frequently diagnosed cancer in men in the Unites States. Nearly 1 million prostate biopsy procedures are performed in the United States annually and elevated prostate-specific antigen (PSA) level is the primary reason for prostate biopsy in \> 90% of cases. However, at the PSA levels which trigger prostate biopsy, often no cancer is found in prostate biopsy specimens. PSA test can be elevated due to reasons other than cancer such as inflammation or natural variation in the level. Investigators plan to treat men with elevated PSA level with over the counter anti-inflammatory medications (ibuprofen, naproxen) to see if the PSA level will decrease to an acceptable level.
Recruiting
3 awards
Phase 4
1 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
More about Badar M. Mian, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Badar M. Mian, MD has experience with
- Docetaxel
- Systematic Transperineal Biopsy (TP-Bx)
- Systematic Transrectal Biopsy (TR-Bx)
- Targeted Transperineal Biopsy (TP-Bx)
- Targeted Transrectal Biopsy (TR-Bx)
- Ibuprofen Or Naproxen
Breakdown of trials Badar M. Mian, MD has run
Prostate Cancer
Prostate-Specific Antigen
Infections and Infestations
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Badar M. Mian, MD specialize in?
Badar M. Mian, MD focuses on Prostate Cancer and Prostate-Specific Antigen. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are synaptophysin positive.
Is Badar M. Mian, MD currently recruiting for clinical trials?
Yes, Badar M. Mian, MD is currently recruiting for 3 clinical trials in Albany New York. If you're interested in participating, you should apply.
Are there any treatments that Badar M. Mian, MD has studied deeply?
Yes, Badar M. Mian, MD has studied treatments such as Docetaxel, Systematic Transperineal biopsy (TP-Bx), Systematic Transrectal biopsy (TR-Bx).
What is the best way to schedule an appointment with Badar M. Mian, MD?
Apply for one of the trials that Badar M. Mian, MD is conducting.
What is the office address of Badar M. Mian, MD?
The office of Badar M. Mian, MD is located at: Albany Medical Center, Albany, New York 12208 United States. This is the address for their practice at the Albany Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.